Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan 15;200(2):422-431.
doi: 10.4049/jimmunol.1701019.

Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment

Suzanne Ostrand-Rosenberg  1 , Catherine Fenselau  2
Affiliations
Review

Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment

Suzanne Ostrand-Rosenberg et al. J Immunol. .

Abstract

Myeloid-derived suppressor cells (MDSC) are a diverse population of immature myeloid cells that have potent immune-suppressive activity. Studies in both mice and humans have demonstrated that MDSC accumulate in most individuals with cancer, where they promote tumor progression, inhibit antitumor immunity, and are an obstacle to many cancer immunotherapies. As a result, there has been intense interest in understanding the mechanisms and in situ conditions that regulate and sustain MDSC, and the mechanisms MDSC use to promote tumor progression. This article reviews the characterization of MDSC and how they are distinguished from neutrophils, describes the suppressive mechanisms used by MDSC to mediate their effects, and explains the role of proinflammatory mediators and the tumor microenvironment in driving MDSC accumulation, suppressive potency, and survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Phenotype and immune suppressive functions of mouse and human monocytic (M-MDSC) and polymorphonuclear (PMN-MDSC) MDSC
Lin− indicates cells are negative for CD3, CD19, CD20, and CD56.
Figure 2
Figure 2. Cytokines, immune regulatory molecules, and transcription factors control the development, accumulation, suppressive potency, and survival of MDSC
Growth factors, hormones, and transcription factors that regulate myelopoiesis induce the expansion of MDSC in bone marrow. Within the pro-inflammatory tumor microenvironment a variety of cytokines and non-cytokine regulatory proteins are produced by tumor cells and tumor-infiltrating host cells (e.g. DCs, lymphocytes, macrophages, mast cells, and fibroblasts) and increase MDSC suppressive potency by activating transcription factors and signal transduction pathways in MDSC. Survival of MDSC is mediated by many of the same factors/conditions that induce the accumulation of MDSC plus cell surface receptors and genes that prevent/limit apoptosis.
Figure 3
Figure 3. MDSC use a variety of immune and non-immune mechanisms to promote tumor progression, but have beneficial effects in other settings
In individuals with cancer, MDSC inhibit adaptive antitumor immunity by suppressing CD4+ and CD8+ T cell activation and function, and by driving and recruiting T regulatory cells. They inhibit innate immunity by polarizing macrophages towards a type 2 tumor-promoting phenotype and by inhibiting NK-mediated cytotoxicity. MDSC also promote cancer cell stemness and facilitate angiogenesis and drive tumor invasion and metastasis. Beneficial effects of MDSC include their lowering of blood glucose levels and reduction of insulin tolerance in obese individuals, and their maintenance of maternal-fetal tolerance and embryo implantation during pregnancy.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gabrilovich DI, Bronte V, Chen SH, Colombo MP, Ochoa A, Ostrand-Rosenberg S, Schreiber H. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 2007;67:425. author reply 426. - PMC - PubMed
    1. Strober S. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. Annu. Rev. Immunol. 1984;2:219–237. - PubMed
    1. Choi KL, Maier T, Holda JH, Claman HN. Suppression of cytotoxic T-cell generation by natural suppressor cells from mice with GVHD is partially reversed by indomethacin. Cellular immunology. 1988;112:271–278. - PubMed
    1. Subiza JL, Vinuela JE, Rodriguez R, Gil J, Figueredo MA, De La Concha EG. Development of splenic natural suppressor (NS) cells in Ehrlich tumor-bearing mice. International journal of cancer. 1989;44:307–314. - PubMed
    1. Young MR, Aquino S, Young ME. Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants. J Leukoc Biol. 1989;45:262–273. - PubMed

Publication types